Systematic Review
Published on 11 Aug 2020
Gemcitabine-Based Neoadjuvant Treatment in Borderline Resectable Pancreatic Ductal Adenocarcinoma: A Meta-Analysis of Individual Patient Data
in Surgical Oncology
Frontiers in Oncology
doi 10.3389/fonc.2020.01112
- 5,815 views
- 14 citations
